Renovion is a clinical stage pharmaceutical company with a nebulized therapy that restores mucus clearance and reduces inflammation in the lungs. The company is focused on developing ARINA-1 for orphan chronic inflammatory lung diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/18/20 | $8,100,000 | Series A |
White Rock Capital Management | undisclosed |
